Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05035017 · ClinicalTrials.gov registry record
Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses
A clinical trial of Myopia, sponsored by CooperVision.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT05035017: Completed study of Myopia, sponsored by CooperVision.
NCT05035017 is a study of Myopia that has completed, run by CooperVision. The registered enrollment target is 35 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05035017, a study of Myopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to confirm the design specifications of a Test lens and validate its clinical performance.
Primary Outcome
Participants rated their overall comfort once after 2 days of wear a 0-100 integer scale, where 0=Cannot be tolerated and 100=Excellent comfort.
Conditions Studied
Interventions
- DEVICE Test Lens
- DEVICE Control Lens
Study Locations (1)
Indiana
- Indiana University School of Optometry - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2021-07-31 |
What the finished NCT05035017 record still lists
NCT05035017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test Lens is the first listed.
NCT05035017 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05035017 about?
NCT05035017 is a clinical study titled "Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses". The purpose of this study was to confirm the design specifications of a Test lens and validate its clinical performance.
What is the current status of trial NCT05035017?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2021-06-17. Estimated completion is 2021-07-31.
What conditions does trial NCT05035017 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05035017?
The interventions under investigation include: Test Lens (DEVICE), Control Lens (DEVICE).
Who is sponsoring clinical trial NCT05035017?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05035017 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05035017's enrollment target sits among peer trials
35 81st of 90 higher than 9 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI